BlackRock Japan’s Biostage, Inc. Common Stock BSTG Stock Holding History

BlackRock Japan’s Portfolio BSTG Stock Details BSTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-5,627	Closed	-$59K	–	1369
2014 Q2	$59K	Sell	5,627 -1,965	-26%	-$16.7K	﹤0.01%	1011
2014 Q1	$69K	Sell	7,592 -472	-6%	-$2.8K	﹤0.01%	1116
2013 Q4	$38K	Buy	+8,064	New	+$37.7K	﹤0.01%	1166

Other funds holding BSTG

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

HSA

Hussman Strategic Advisors Ellicott City, Maryland $463M AUM 16% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Japan's BSTG Position: Q3 2014 in Review

BlackRock Japan sold out of Biostage, Inc. Common Stock (BSTG) in Q3 2014, closing a stake of 5,627 shares — an estimated $59K sold.

BlackRock Japan first reported a position in BSTG in Q4 2013 and held it in 3 quarters. The position peaked at $69K in Q1 2014. 43 funds tracked by Wall St. Rank hold BSTG as of Q3 2014.

BlackRock Japan reported no remaining Biostage, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
BlackRock Japan sold 5,627 Biostage, Inc. Common Stock shares in Q3 2014, an estimated $59K.
BlackRock Japan first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 3 quarters.
BlackRock Japan's Biostage, Inc. Common Stock position peaked at $69K in Q1 2014.
43 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q3 2014.

Based on BlackRock Japan's 13F filing for Q3 2014, filed 29 Oct 2014.